(Q34049729)

English

The effects of hormone replacement therapy on thrombin generation, fibrinolysis inhibition, and resistance to activated protein C: prospective cohort study and review of literature

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

The effects of hormone replacement therapy on thrombin generation, fibrinolysis inhibition, and resistance to activated protein C: prospective cohort study and review of literature (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Hormone Replacement Therapy

1 reference

based on heuristic

inferred from title

drotrecogin alfa

1 reference

based on heuristic

inferred from title

author name string

Douketis JD

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Gordon M

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Johnston M

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Julian JA

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Adachi JR

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Ginsberg JS

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

1 July 2000

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Thrombosis Research

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

99

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

25-34

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900217-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of venous thromboembolism in users of hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900217-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective study of exogenous hormones and risk of pulmonary embolism in women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900217-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hormone replacement therapy and risk of venous thromboembolism: population based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900217-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900217-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance to activated protein C in healthy women taking oral contraceptives.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900217-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900217-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of resistance to activated protein C during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900217-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The fibrinolytic enzyme system and its role in the etiology of thromboembolic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900217-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900217-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Fibrinolytic potential is significantly increased by oestrogen treatment in postmenopausal women with mild dyslipidaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900217-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Coagulation activation following estrogen administration to postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900217-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900217-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular risk factors and combined estrogen-progestin replacement therapy: a placebo-controlled study with nomegestrol acetate and estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900217-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900217-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Haemostatic changes during continuous oestradiol-progestogen treatment of postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900217-6

7 January 2021

based on heuristic

inferred from DOI database lookup

EFFECTS OF ESTROGEN REPLACEMENT THERAPY ON THROMBIN GENERATION

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900217-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of estrogen replacement therapy with or without progestogen on the fibrinolytic system and coagulation inhibitors in postmenopausal status

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900217-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Short- and long-term effects of hormone replacement therapy (transdermal estradiol vs oral conjugated equine estrogens, combined with medroxyprogesterone acetate) on blood coagulation factors in posimenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900217-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of hormone replacement therapy on hemostatic cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900217-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900217-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900217-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900217-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900217-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900217-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0049-3848(00)00217-6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34049729&oldid=1538651063"